Radiotherapy, Adjuvant

• 

  Subject Areas on Research

  • A Hybrid Approach to Radiation-Induced Axillary Artery Hemorrhage. 
  • A Multi-Institutional Analysis of Adjuvant Chemotherapy and Radiation Sequence in Women With Stage IIIC Endometrial Cancer. 
  • A framework to evaluate the cost-effectiveness of the NADiA ProsVue slope to guide adjuvant radiotherapy among men with high-risk characteristics following prostatectomy for prostate cancer. 
  • A multi-institutional cohort study of adjuvant therapy in stage I-II uterine carcinosarcoma. 
  • A multi-institutional study of outcomes in stage I-III uterine carcinosarcoma. 
  • A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancer. 
  • A phase I study of dose-dense topotecan given upfront to standard therapy in patients with small cell lung cancer. 
  • A phase II study of induction chemotherapy followed by thoracic radiotherapy and erlotinib in poor-risk stage III non-small-cell lung cancer: results of CALGB 30605 (Alliance)/RTOG 0972 (NRG). 
  • A preliminary assessment of guideline adherence and clinical variation in oral cancer treatment: a MarketScan database study. 
  • A prospective pathologic analysis using whole-mount sections of rectal cancer following preoperative combined modality therapy: implications for sphincter preservation. 
  • A validation study of a new prognostic index for patients with brain metastases: the Graded Prognostic Assessment. 
  • ACR Appropriateness Criteria(®) Aggressive Nonmelanomatous Skin Cancer of the Head and Neck. 
  • ATM Variants in Breast Cancer: Implications for Breast Radiation Therapy Treatment Recommendations. 
  • Active Breathing Coordinator reduces radiation dose to the heart and preserves local control in patients with left breast cancer: report of a prospective trial. 
  • Adenoid cystic carcinoma of the paranasal sinuses. 
  • Adequate lymph node assessment for extrahepatic bile duct adenocarcinoma. 
  • Adjuvant Radiation Therapy for Clinical Stage III Melanoma in the Modern Therapeutic Era. 
  • Adjuvant Therapy for Patients With Early Large Cell Lung Neuroendocrine Cancer: A National Analysis. 
  • Adjuvant and salvage radiation therapy after prostatectomy: American Society for Radiation Oncology/American Urological Association guidelines. 
  • Adjuvant and salvage radiotherapy after prostatectomy: AUA/ASTRO Guideline. 
  • Adjuvant external-beam radiotherapy with concurrent chemotherapy after resection of primary gallbladder carcinoma: a 23-year experience. 
  • Adjuvant radiation therapy for distal pancreatic cancer: is there a role? 
  • Adjuvant radiation therapy increases disease-free survival in stage IB Merkel cell carcinoma. 
  • Adjuvant radioactive iodine therapy is associated with improved survival for patients with intermediate-risk papillary thyroid cancer. 
  • Adjuvant radiotherapy for pathologic stage T3/4 adenocarcinoma of the prostate: ten-year update. 
  • Adjuvant radiotherapy in the treatment of invasive intraductal papillary mucinous neoplasm of the pancreas: an analysis of the surveillance, epidemiology, and end results registry. 
  • Adjuvant radiotherapy with and without concurrent chemotherapy for locally advanced transitional cell carcinoma of the renal pelvis and ureter. 
  • Adjuvant therapy for colorectal cancer. 
  • Adjuvant therapy for pancreatic cancer: an evolving paradigm. 
  • Adjuvant therapy for pancreatic cancer: current status and future directions. 
  • Adjuvant therapy in rectal cancer: analysis of stage, sex, and local control--final report of intergroup 0114. 
  • Adjuvant treatment and outcomes for patients with stage IIIA grade 1 endometrioid endometrial cancer. 
  • Adjuvant versus salvage radiation therapy for prostate cancer and the risk of death. 
  • Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens. 
  • Adverse pathology and undetectable ultrasensitive prostate-specific antigen after radical prostatectomy: is adjuvant radiation warranted? 
  • Age-related disparities in the use of radiotherapy for treatment of localized soft tissue sarcoma. 
  • Aggressive multimodality treatment of invasive thymic carcinoma. 
  • Anal cancer. American College of Radiology. ACR Appropriateness Criteria. 
  • Analysis of perioperative radiation therapy in the surgical treatment of primary and recurrent retroperitoneal sarcoma. 
  • Anaplastic extramedullary cervical ependymoma with leptomeningeal metastasis. 
  • Anaplastic large cell lymphoma associated with breast implants: a report of 13 cases. 
  • Antiangiogenics: the potential role of integrating this novel treatment modality with chemoradiation for solid cancers. 
  • Appendiceal carcinoma: patterns of failure following surgery and implications for adjuvant therapy. 
  • Applying the neoadjuvant paradigm to ductal carcinoma in situ. 
  • Assessing adverse events of postprostatectomy radiation therapy for prostate cancer: evaluation of outcomes in the Regione Emilia-Romagna, Italy. 
  • Assessment of multimodality therapy use for extremity sarcoma in the United States. 
  • Association between single nucleotide polymorphisms of the transforming growth factor β1 gene and the risk of severe radiation esophagitis in patients with lung cancer. 
  • Benefit of delayed primary excision in rhabdomyosarcoma: A report from the Children's Oncology Group. 
  • Bevacizumab for the treatment of high-grade glioma. 
  • Beyond 5-fluorouracil: the emerging role of newer chemotherapeutics and targeted agents with radiation therapy. 
  • Body mass index, dose to organs at risk during vaginal brachytherapy, and the role of three-dimensional CT-based treatment planning. 
  • Breast conservation rates-barriers between tertiary care and community practice. 
  • Breast conservation surgery using nipple-areolar resection for central breast cancers. 
  • Cancer-related fatigue. 
  • Carcinoma of the Middle Ear: A Review of the National Cancer Database. 
  • Carcinoma of the vulva: combined modality treatment. 
  • Cardiorespiratory fitness in breast cancer patients: a call for normative values. 
  • Cerebellar malignant fibrous histiocytoma: case report and literature review. 
  • Cerebellopontine angle craniopharyngioma: case report and literature review. 
  • Characteristics associated with swallowing changes after concurrent chemotherapy and radiotherapy in patients with head and neck cancer. 
  • Chemoradiation for localized pancreatic cancer: another perspective. 
  • Chemoradiotherapy for locoregionally advanced squamous cell carcinoma of the base of tongue. 
  • Chemotherapeutic and biologic agents as radiosensitizers in rectal cancer. 
  • Chemotherapy or Combined Modality Therapy for Early-stage Hodgkin Lymphoma. 
  • Clear cell adenocarcinoma in a female urethral diverticulum. 
  • Clinical Utility of the 12-Gene DCIS Score Assay: Impact on Radiotherapy Recommendations for Patients with Ductal Carcinoma In Situ. 
  • Clinical examination following preoperative chemoradiation for rectal cancer is not a reliable surrogate end point. 
  • Clinical outcome after neoadjuvant thermoradiotherapy in high grade soft tissue sarcomas. 
  • Clinical physics, applicator choice, technique, and equipment for electron intraoperative radiation therapy. 
  • Clinical predictors of larynx preservation after multiagent concurrent chemoradiotherapy. 
  • Clinicopathologic features and treatment in patients with early stage uterine clear cell carcinoma: A 16-year experience. 
  • Colorectal cancer. 
  • Colorectal cancer: adjuvant chemotherapy for rectal cancer-an unresolved issue. 
  • Combined modality therapy for rectal and colon cancer. 
  • Combined modality treatment for rectal cancer. 
  • Combined-modality therapy for early-stage Hodgkin lymphoma: maintaining high cure rates while minimizing risks. 
  • Combined-modality therapy for rectal cancer: future prospects. 
  • Combined-modality therapy versus radiotherapy alone for treatment of early-stage Hodgkin's disease: cure balanced against complications. 
  • Comparison Between Adjuvant and Early-Salvage Postprostatectomy Radiotherapy for Prostate Cancer With Adverse Pathological Features. 
  • Complete Surgical Excision Is Essential for the Management of Patients With Breast Implant-Associated Anaplastic Large-Cell Lymphoma. 
  • Complete response to neoadjuvant chemoradiation for rectal cancer does not influence survival. 
  • Complications of pancreaticoduodenectomy after neoadjuvant chemoradiation in patients with and without preoperative biliary drainage. 
  • Controversies in the treatment of prostate cancer with maximal androgen deprivation. 
  • Cost Implications of an Evidence-Based Approach to Radiation Treatment After Lumpectomy for Early-Stage Breast Cancer. 
  • Cost-effectiveness of adjuvant radiotherapy in intermediate risk endometrial cancer. 
  • Current Trends in the Management of Ductal Carcinoma In Situ. 
  • Cyberknife hypofractionated stereotactic radiosurgery (HSRS) of resection cavity after excision of large cerebral metastasis: efficacy and safety of an 800 cGy × 3 daily fractions regimen. 
  • Defining the Place of Adjuvant Chemotherapy and Radiation for High-Risk Endometrial Cancer From Recent Randomized Clinical Trials: Some Answers, More Questions. 
  • Deformable registration of preoperative PET/CT with postoperative radiation therapy planning CT in head and neck cancer. 
  • Delayed recovery after pancreaticoduodenectomy: a major factor impairing the delivery of adjuvant therapy? 
  • Desmoid tumors of the chest wall. 
  • Diagnosis and treatment of stage-III peripheral squamous cell carcinoma of right upper lung. 
  • Does Prophylactic Paraortic Lymph Node Irradiation Improve Outcomes in Women With Stage IIIC1 Endometrial Carcinoma? 
  • Does adjuvant chemotherapy improve survival for women with early-stage uterine leiomyosarcoma? 
  • Does postoperative irradiation play a role in the adjuvant therapy of stage T4 colon cancer? 
  • Does surgery improve outcomes for esophageal squamous cell carcinoma? An analysis using the surveillance epidemiology and end results registry from 1998 to 2008. 
  • Does vocal cord fixation preclude nonsurgical management of laryngeal cancer? 
  • Dosimetric and radiobiologic comparison of 3D conformal versus intensity modulated planning techniques for prostate bed radiotherapy. 
  • Downstaging therapy followed by liver transplantation for hepatocellular carcinoma beyond Milan criteria. 
  • Early Adoption of the SSO-ASTRO Consensus Guidelines on Margins for Breast-Conserving Surgery with Whole-Breast Irradiation in Stage I and II Invasive Breast Cancer: Initial Experience from Memorial Sloan Kettering Cancer Center. 
  • Early breast cancer therapy and cardiovascular injury. 
  • Effect of esthetic outcome after breast-conserving surgery on psychosocial functioning and quality of life. 
  • Effect of neoadjuvant chemoradiation on operative mortality and morbidity for pancreaticoduodenectomy. 
  • Effect of primary prophylactic G-CSF use on systemic therapy administration for elderly breast cancer patients. 
  • Equivalent Treatment and Survival after Resection of Pancreatic Cancer at Safety-Net Hospitals. 
  • Evaluation of Adjuvant Radiation Therapy for Resected Gallbladder Carcinoma: A Multi-institutional Experience. 
  • Evaluation of preoperative therapy for pancreatic cancer using a prognostic nomogram. 
  • Ewing's sarcoma of the hand. 
  • Extent of neck dissection required after concurrent chemoradiation for stage IV head and neck squamous cell carcinoma. 
  • External beam radiation therapy after radical prostatectomy: efficacy and impact on urinary continence. 
  • Feasibility trial of partial breast irradiation with concurrent dose-dense doxorubicin and cyclophosphamide in early-stage breast cancer. 
  • Fibromatoses in childhood: the desmoid/fibromatosis complex. 
  • Fifteen-year median follow-up results after neoadjuvant doxorubicin, followed by mastectomy, followed by adjuvant cyclophosphamide, methotrexate, and fluorouracil (CMF) followed by radiation for stage III breast cancer: a phase II trial (CALGB 8944). 
  • Gastric surgical adjuvant radiotherapy consensus report: rationale and treatment implementation. 
  • Heterotopic ossification in rectal cancer: Rare finding with a novel proposed mechanism. 
  • High-dose therapy and autologous bone marrow transplantation for follicular lymphoma in first complete or partial remission: results of a phase II clinical trial. 
  • Higher symptom burden is associated with lower function in women taking adjuvant endocrine therapy for breast cancer. 
  • Identification of distant metastases with PET-CT in patients with suspected recurrent head and neck cancer. 
  • Identification of distinct and overlapping cortical areas for bilingual naming and reading using cortical stimulation. Case report. 
  • Immediate Breast Reconstruction Allows for the Timely Initiation of Postmastectomy Radiation Therapy. 
  • Immunologic Consequences of Sequencing Cancer Radiotherapy and Surgery. 
  • Immunologic escape after prolonged progression-free survival with epidermal growth factor receptor variant III peptide vaccination in patients with newly diagnosed glioblastoma. 
  • Impact of Positive Margins and Radiation After Tracheal Adenoid Cystic Carcinoma Resection on Survival. 
  • Impact of body mass index on outcomes and treatment-related toxicity in patients with stage II and III rectal cancer: findings from Intergroup Trial 0114. 
  • Impact of hospital procedure volume on surgical operation and long-term outcomes in high-risk curatively resected rectal cancer: findings from the Intergroup 0114 Study. 
  • Impact of minimally invasive vs. open distal pancreatectomy on use of adjuvant chemoradiation for pancreatic adenocarcinoma. 
  • Impact of postoperative prostate-specific antigen disease recurrence and the use of salvage therapy on the risk of death. 
  • Impact of prior local therapy on overall survival in men with metastatic castration-resistant prostate cancer: Results from Shared Equal Access Regional Cancer Hospital. 
  • Impact of radical prostatectomy in the management of clinically localized disease. 
  • Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial. 
  • Improving understanding of adjuvant therapy options by using simpler risk graphics. 
  • Incidence and risk factors of significant carotid artery stenosis in asymptomatic survivors of head and neck cancer after radiotherapy. 
  • Increased toxicity with gefitinib, capecitabine, and radiation therapy in pancreatic and rectal cancer: phase I trial results. 
  • Induction therapy does not improve survival for clinical stage T2N0 esophageal cancer. 
  • Initiation of salvage therapy for prostate cancer. 
  • Intensified adjuvant combined modality therapy for resected periampullary adenocarcinoma: acceptable toxicity and suggestion of improved 1-year disease-free survival. 
  • Intensity-modulated radiotherapy for resected mesothelioma: the Duke experience. 
  • Intensive concomitant chemoradiotherapy in locally advanced unresectable squamous cell carcinoma of the head and neck: a phase II study of radiotherapy with cisplatin and 7-week continuous infusional fluorouracil. 
  • Internal fixation of radiation-induced pathological fractures of the femur has a high rate of failure. 
  • Intraocular Ki-1 lymphoma in a 2-year-old boy. 
  • Intraoperative radiation therapy in resected bile duct cancer. 
  • Intraoperative radiation therapy in the management of gynecologic and genitourinary malignancies. 
  • Intraoperative radiation therapy. 
  • Invasive Breast Cancer Version 1.2016, NCCN Clinical Practice Guidelines in Oncology. 
  • Investigating confounders of the association between survival and adjuvant radiation therapy after breast conserving surgery in a sample of elderly breast Cancer patients in Appalachia. 
  • Is radiation indicated in patients with ductal carcinoma in situ and close or positive mastectomy margins? 
  • Is there a role for adjuvant therapy in resected adenocarcinoma of the small intestine. 
  • Isolated Central Nervous System Chloroma as a Presenting Sign of Relapsed Pediatric Acute Lymphoblastic Leukemia. 
  • Keloid Excision and Adjuvant Treatments: A Network Meta-analysis. 
  • Late onset of isolated central nervous system metastasis of liposarcoma--a case report. 
  • Leiomyosarcoma in childhood and adolescence. 
  • Limited-stage small-cell lung cancer (stages I-III): observations from the National Cancer Data Base. 
  • Liver Transplantation Outcomes in a U.S. Multicenter Cohort of 789 Patients With Hepatocellular Carcinoma Presenting Beyond Milan Criteria. 
  • Local recurrence following initial resection of NSCLC: salvage is possible with radiation therapy. 
  • Local therapy for rectal cancer. 
  • Local-regional recurrence in women with small node-negative, HER2-positive breast cancer: results from a prospective multi-institutional study (the APT trial). 
  • Locally advanced (high-risk) prostate cancer. American College of Radiology. ACR Appropriateness Criteria. 
  • Long-term Oncologic Outcomes After Neoadjuvant Radiation Therapy for Retroperitoneal Sarcomas. 
  • Long-term follow-up of patients with rectal cancer managed by local excision with and without adjuvant irradiation. 
  • Long-term results of therapy for stage C neuroblastoma. 
  • Long-term survival after multidisciplinary management of resected pancreatic adenocarcinoma. 
  • Low local recurrence rate without postmastectomy radiation in node-negative breast cancer patients with tumors 5 cm and larger. 
  • Low morbidity and mortality for bronchoplastic procedures with and without induction therapy. 
  • Low-stage medulloblastoma: final analysis of trial comparing standard-dose with reduced-dose neuraxis irradiation. 
  • MSH6 inactivation and emergent temozolomide resistance in human glioblastomas. 
  • Management of extremity soft tissue sarcomas with limb-sparing surgery and postoperative irradiation: do total dose, overall treatment time, and the surgery-radiotherapy interval impact on local control? 
  • Management of locally advanced adenocarcinoma of the pancreas. 
  • Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015. 
  • Management of resectable rectal cancer. American College of Radiology. ACR Appropriateness Criteria. 
  • Maximizing Tumor Control and Limiting Complications With Stereotactic Body Radiation Therapy for Pancreatic Cancer. 
  • Measurement and Variation in Estimation of Quality of Life Effects of Patients Undergoing Treatment for Papillary Thyroid Carcinoma. 
  • Medical Facts versus Value Judgments--Toward Preference-Sensitive Guidelines. 
  • Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer. 
  • Minimally invasive gastrectomy for gastric cancer: A national perspective on oncologic outcomes and overall survival. 
  • Mobile spine chordoma: results of 166 patients from the AOSpine Knowledge Forum Tumor database. 
  • Modeling killing and repopulation kinetics of subclinical cancer: direct calculations from clinical data. 
  • Multiagent concurrent chemoradiotherapy for locoregionally advanced squamous cell head and neck cancer: mature results from a single institution. 
  • Multicenter analysis of recurrence and survival in stage IIIA endometrial cancer. 
  • Multidisciplinary approach to treatment of radiation-induced chest wall sarcoma. 
  • Multimodality management of locally advanced rectal cancer. 
  • Multimodality therapy for locoregional extrahepatic cholangiocarcinoma: a population-based analysis. 
  • Multiple Myeloma, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology. 
  • NCCN Guidelines Insights: Bladder Cancer, Version 5.2018. 
  • Nasal Cavity Squamous Cell Carcinoma: Factors Associated With Treatment Outcomes and Potential Organ Preservation. 
  • Nationwide trends and outcomes associated with neoadjuvant therapy in pancreatic cancer: An analysis of 18 243 patients. 
  • Neoadjuvant Radiation Therapy and Surgery Improves Metastasis-Free Survival over Surgery Alone in a Primary Mouse Model of Soft Tissue Sarcoma. 
  • Neoadjuvant chemoradiation for adenocarcinoma of the pancreas. 
  • Neoadjuvant chemoradiation for adenocarcinoma of the pancreas. 
  • Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: treatment variables and survival duration. 
  • Neuroendocrine small cell carcinoma of the uterine cervix: what disease? What treatment? Report of ten cases and a review of the literature. 
  • Never too old? Age should not be a barrier to enrollment in cancer clinical trials. 
  • New Developments in the Management of Cutaneous Squamous Cell Carcinoma. 
  • New approaches to assessing and treating early-stage colon and rectal cancer: summary statement from 2007 Santa Monica Conference. 
  • No Difference in Survival between Neo-Adjuvant Chemotherapy and Neo-Adjuvant Chemoradiation Therapy in Gastric Cardia Cancer Patients: A Contemporary View from the National Cancer Database. 
  • Nodal Response to Neoadjuvant Chemotherapy Predicts Receipt of Radiation Therapy After Breast Cancer Diagnosis. 
  • Nodal downstaging predicts survival following induction chemotherapy for stage IIIA (N2) non-small cell lung cancer in CALGB protocol #8935. 
  • Node-positive prostate cancer. American College of Radiology. ACR Appropriateness Criteria. 
  • Omission of Radiation in Conservative Treatment for Breast Cancer: Opportunity for De-escalation of Care. 
  • Optimizing Adjuvant Treatment Recommendations for Older Women with Biologically Favorable Breast Cancer: Short-Course Radiation or Long-Course Endocrine Therapy? 
  • Outcomes after total skin-sparing mastectomy and immediate reconstruction in 657 breasts. 
  • Outcomes and Predictive Value of Post-adjuvant Therapy PET/CT for Locally Advanced Oral Squamous Cell Carcinoma. 
  • Outcomes in surgical stage I uterine papillary serous carcinoma. 
  • Overcoming Resistance - Omission of Radiotherapy for Low-Risk Breast Cancer. 
  • Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. 
  • Paclitaxel-based chemoradiotherapy in the treatment of patients with operable esophageal cancer. 
  • Pain, quality of life, and spinal accessory nerve status after neck dissection. 
  • Pancreatic adenocarcinoma. Clinical Practice Guidelines in Oncology. 
  • Pancreatic adenocarcinoma: Clinical Practice Guidelines in Oncology. 
  • Pancreatic cancer: future outlook, promising trials, newer systemic agents, and strategies from the Gastrointestinal Intergroup Pancreatic Cancer Task Force. 
  • Pancreatic neuroendocrine tumors with involved surgical margins: prognostic factors and the role of adjuvant radiotherapy. 
  • Pathologic complete response to neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma is associated with a better prognosis. 
  • Patterns of Care and Age-Specific Impact of Extent of Resection and Adjuvant Radiotherapy in Pediatric Pineoblastoma. 
  • Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935. 
  • Persistent N2 disease after neoadjuvant chemotherapy for non-small-cell lung cancer. 
  • Phase 1 trial of neoadjuvant radiation therapy before prostatectomy for high-risk prostate cancer. 
  • Phase I trial evaluating the safety of bevacizumab with concurrent radiotherapy and capecitabine in locally advanced pancreatic cancer. 
  • Phase I/II study of preoperative oxaliplatin, fluorouracil, and external-beam radiation therapy in patients with locally advanced rectal cancer: Cancer and Leukemia Group B 89901. 
  • Phase II study of bevacizumab with concurrent capecitabine and radiation followed by maintenance gemcitabine and bevacizumab for locally advanced pancreatic cancer: Radiation Therapy Oncology Group RTOG 0411. 
  • Phase II trial of cetuximab, gemcitabine, and oxaliplatin followed by chemoradiation with cetuximab for locally advanced (T4) pancreatic adenocarcinoma: correlation of Smad4(Dpc4) immunostaining with pattern of disease progression. 
  • Phase II trial of preoperative chemoradiation in patients with localized gastric adenocarcinoma (RTOG 9904): quality of combined modality therapy and pathologic response. 
  • Phase III study of adjuvant chemotherapy and radiation therapy compared with chemotherapy alone in the surgical adjuvant treatment of colon cancer: results of intergroup protocol 0130. 
  • Polymorphisms of p16, p27, p73, and MDM2 modulate response and survival of pancreatic cancer patients treated with preoperative chemoradiation. 
  • Post-mastectomy radiation in large node-negative breast tumors: does size really matter? 
  • Post-therapy pathologic stage and survival in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant chemoradiation. 
  • Postmastectomy Radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update. 
  • Postmastectomy Radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update. 
  • Postoperative Radiation Therapy for Prostate Cancer: Comparison of Conventional Versus Hypofractionated Radiation Regimens. 
  • Postoperative chemotherapy and delayed radiation in infants and very young children with choroid plexus carcinomas. The Pediatric Oncology Group. 
  • Postoperative prostate-specific antigen as a prognostic indicator in patients with margin-positive prostate cancer, undergoing adjuvant radiotherapy after radical prostatectomy. 
  • Postoperative radiation therapy for lung cancer: where do we stand? 
  • Postoperative radiotherapy is associated with improved overall survival for alveolar ridge squamous cell carcinoma with adverse pathologic features. 
  • Postradical prostatectomy irradiation in carcinoma of the prostate. American College of Radiology. ACR Appropriateness Criteria. 
  • Postresection CA 19-9 predicts overall survival in patients with pancreatic cancer treated with adjuvant chemoradiation: a prospective validation by RTOG 9704. 
  • Practice patterns in the delivery of radiation therapy after mastectomy among the University of California Athena Breast Health Network. 
  • Predicting response to adjuvant and radiation therapy in patients with early stage breast carcinoma. 
  • Prediction model to estimate overall survival benefit of postoperative radiotherapy for resected major salivary gland cancers. 
  • Predictors of Long-Term Quality of Life for Survivors of Stage II/III Rectal Cancer in the Cancer Care Outcomes Research and Surveillance Consortium. 
  • Predictors of reduced dose intensity in patients with early-stage breast cancer receiving adjuvant chemotherapy. 
  • Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas. 
  • Preoperative chemoradiation for patients with locally advanced adenocarcinoma of the pancreas. 
  • Preoperative chemoradiation strategies for localized adenocarcinoma of the pancreas. 
  • Preoperative concurrent chemotherapy and radiotherapy in rectal cancer patients. 
  • Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head. 
  • Preoperative infusional chemoradiation and surgery with or without an electron beam intraoperative boost for advanced primary rectal cancer. 
  • Preoperative or postoperative radiotherapy versus surgery alone for retroperitoneal sarcoma: a case-control, propensity score-matched analysis of a nationwide clinical oncology database. 
  • Preoperative radiation therapy in the surgical management of gastric and junctional adenocarcinoma: Should lymph node retrieval guidelines be altered? 
  • Preoperative radiotherapy for rectal cancer: benefits and controversies. 
  • Primary Versus Preoperative Radiation for Locally Advanced Vulvar Cancer. 
  • Primary pediatric intraspinal sarcomas. Report of 3 cases. 
  • Prognostic factors in stage T3N0 rectal cancer: do all patients require postoperative pelvic irradiation and chemotherapy? 
  • Prognostic significance of depth of gross or microscopic perirectal fat invasion in T3 N0 M0 rectal cancers following sharp mesorectal excision and no adjuvant therapy. 
  • Progressive outer retinal necrosis. 
  • Promising survival and concomitant radiation plus temozolomide followed by adjuvant temozolomide. 
  • Prostate cancer. 
  • Pubic Bone Osteomyelitis and Pubosymphyseal Urinary Fistula: A Poorly Recognized Complication in Prostate Cancer Survivors. 
  • Quality measures for the use of adjuvant chemotherapy and radiation therapy in patients with colorectal cancer: a systematic review. 
  • Quality of life after postmastectomy radiotherapy in patients with intermediate-risk breast cancer (SUPREMO): 2-year follow-up results of a randomised controlled trial. 
  • Radiation Therapy for Soft Tissue Sarcoma: Indications and Controversies for Neoadjuvant Therapy, Adjuvant Therapy, Intraoperative Radiation Therapy, and Brachytherapy. 
  • Radical hysterectomy and pelvic lymphadenectomy for stage IB2 cervical cancer. 
  • Radioactive Iodine Treatment Is Associated with Improved Survival for Patients with Hürthle Cell Carcinoma. 
  • Radiotherapy after mastectomy. 
  • Radiotherapy following radical prostatectomy. 
  • Randomized phase II study of neoadjuvant combined-modality chemoradiation for distal rectal cancer: Radiation Therapy Oncology Group Trial 0012. 
  • Rapid-fractionation pre-operative chemoradiation for malignant periampullary neoplasms. 
  • Rapid-fractionation preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for resectable pancreatic adenocarcinoma. 
  • Rare breast metastasis from adenoid cystic carcinoma of the submandibular gland. 
  • Recent advances in the treatment of pediatric brain tumors. 
  • Rectal cancer: presentation with metastatic and locally advanced disease. American College of Radiology. ACR Appropriateness Criteria. 
  • Recurrence After Partial Hepatectomy for Metastatic Colorectal Cancer: Potentially Curative Role of Salvage Repeat Resection. 
  • Recurrence after complete resection and selective use of adjuvant therapy for stage I through III Merkel cell carcinoma. 
  • Reply to J. Stenman et al. 
  • Resected pancreatic neuroendocrine tumors: patterns of failure and disease-related outcomes with or without radiotherapy. 
  • Resection of lymph node metastases influences survival in stage IIIC endometrial cancer. 
  • Results of cancer and leukemia group B protocol 8935. A multiinstitutional phase II trimodality trial for stage IIIA (N2) non-small-cell lung cancer. Cancer and Leukemia Group B Thoracic Surgery Group. 
  • Rising PSA in nonmetastatic prostate cancer. 
  • Robot-assisted laparoscopic prostatectomy is not associated with early postoperative radiation therapy. 
  • Role of Adjuvant Therapy in a Population-Based Cohort of Patients With Early-Stage Small-Cell Lung Cancer. 
  • Role of radiation therapy in patients with resectable pancreatic cancer. 
  • SEER insights. 
  • Safety of immediate transverse rectus abdominis myocutaneous breast reconstruction for patients with locally advanced disease. 
  • Second malignancies in young children with primary brain tumors following treatment with prolonged postoperative chemotherapy and delayed irradiation: a Pediatric Oncology Group study. 
  • Sequential preoperative fluorodeoxyglucose-positron emission tomography assessment of response to preoperative chemoradiation: a means for determining longterm outcomes of rectal cancer. 
  • Serum CA 19-9 as a marker of resectability and survival in patients with potentially resectable pancreatic cancer treated with neoadjuvant chemoradiation. 
  • Significance of histological response to preoperative chemoradiotherapy for pancreatic cancer. 
  • Simulation Modeling of Cancer Clinical Trials: Application to Omitting Radiotherapy in Low-risk Breast Cancer. 
  • Simultaneously detected bilateral testicular cancer of different histopathological origin--a challenging situation for the urologist. 
  • Sinonasal Squamous Cell Carcinoma Outcomes: Does Treatment at a High-Volume Center Confer Survival Benefit? 
  • Small-cell lung cancer: a review of clinical trials. 
  • Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. 
  • Society of Surgical Oncology-American Society for Radiation Oncology-American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery with Whole-Breast Irradiation in Ductal Carcinoma In Situ. 
  • Sphincter preservation in rectal cancer. Local excision followed by postoperative radiation therapy. 
  • Sphincter-sparing treatment for distal rectal adenocarcinoma. 
  • Squamous cell carcinoma of the oropharynx and hypopharynx. 
  • Squamous cell carcinoma of the temporal bone: a radiographic-pathologic correlation. 
  • Stage III lung cancer: two or three modalities? The continued role of thoracic radiotherapy. 
  • Staging of pancreatic cancer before and after neoadjuvant chemoradiation. 
  • Standardization of lower extremity quantitative lymphedema measurements and associated patient-reported outcomes in gynecologic cancers. 
  • Stopping a clinical trial early: frequentist and Bayesian approaches applied to a CALGB trial in non-small-cell lung cancer. 
  • Suppository administration of chemotherapeutic drugs with concomitant radiation for rectal cancer. 
  • Surgical Resection of the Primary Tumor in Women With De Novo Stage IV Breast Cancer: Contemporary Practice Patterns and Survival Analysis. 
  • Surgical candidacy and treatment initiation among women with cervical cancer at public referral hospitals in Kampala, Uganda: a descriptive cohort study. 
  • Surgical resection is necessary to maximize tumor control in function-preserving, aggressive chemoradiation protocols for advanced squamous cancer of the head and neck (stage III and IV). 
  • Surgical strategies and outcomes after induction therapy for non-small cell lung cancer. 
  • Surrogate endpoints for overall survival in chemotherapy and radiotherapy trials in operable and locally advanced lung cancer: a re-analysis of meta-analyses of individual patients' data. 
  • Surveillance of Sentinel Node-Positive Melanoma Patients with Reasons for Exclusion from MSLT-II: Multi-Institutional Propensity Score Matched Analysis. 
  • Survival disadvantage among Medicaid-insured breast cancer patients treated with breast conserving surgery without radiation therapy. 
  • Systemic therapy for older women with breast cancer. 
  • Tailoring Adjuvant Radiation Therapy by Intraoperative Imaging to Detect Residual Cancer. 
  • Technical advances in the treatment of patients with rectal cancer. 
  • Temporal trends in the management of potentially resectable lung cancer. 
  • Testicular cancer. Clinical practice guidelines. 
  • The 1999 patterns of care study of radiotherapy in localized prostate carcinoma: a comprehensive survey of prostate brachytherapy in the United States. 
  • The ASTRO clinical practice guidelines in cervical cancer: Optimizing radiation therapy for improved outcomes. 
  • The Development of Intermediate Clinical Endpoints in Cancer of the Prostate (ICECaP). 
  • The Impact of Pathologically Positive Lymph Nodes in the Clinically Negative Neck: An Analysis of 39,301 Patients with Papillary Thyroid Cancer. 
  • The Role of Radiotherapy for Chordoma Patients Managed With Surgery: Analysis of the National Cancer Database. 
  • The ability of tumor volume to predict local control in surgically treated squamous cell carcinoma of the supraglottic larynx. 
  • The addition of chemotherapy to adjuvant radiation is associated with inferior survival outcomes in intermediate-risk HPV-negative HNSCC. 
  • The clinical management of chondrosarcoma. 
  • The complex triad of obesity, diabetes and race in Type I and II endometrial cancers: prevalence and prognostic significance. 
  • The cost-effectiveness of neoadjuvant chemoradiation is superior to a surgery-first approach in the treatment of pancreatic head adenocarcinoma. 
  • The current clinical value of the DCIS Score. 
  • The effect of neoadjuvant radiation therapy on perioperative outcomes among patients undergoing resection of retroperitoneal sarcomas. 
  • The evaluation and treatment of patients receiving radiation therapy for carcinoma of the esophagus: results of the 1992-1994 Patterns of Care Study. 
  • The feasibility and safety of immunotherapy with dendritic cells loaded with CEA mRNA following neoadjuvant chemoradiotherapy and resection of pancreatic cancer. 
  • The impact of 5-fluorouracil and intraoperative electron beam radiation therapy on the outcome of patients with locally advanced primary rectal and rectosigmoid cancer. 
  • The impact of endocrine therapy on sexual dysfunction in postmenopausal women with early stage breast cancer: encouraging results from a prospective study. 
  • The impact of portal vein resection on outcomes for hilar cholangiocarcinoma: a multi-institutional analysis of 305 cases. 
  • The impact of surgery on ductal carcinoma in situ outcomes: the use of mastectomy. 
  • The influence of adjuvant therapy on survival in patients with indeterminate margins following surgery for non-small cell lung cancer. 
  • The influence of radiation modality and lymph node dissection on survival in early-stage endometrial cancer. 
  • The prognostic significance of positive peritoneal cytology and adnexal/serosal metastasis in stage IIIA endometrial cancer. 
  • The role of androgen deprivation therapy combined with prostate brachytherapy. 
  • The role of intraoperative radiation therapy in patients with pancreatic cancer. 
  • The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer. 
  • The role of optimal debulking in advanced stage serous carcinoma of the uterus. 
  • The treatment of malignant brain tumors in infants and very young children: an update of the Pediatric Oncology Group experience. 
  • The use of adjuvant radiotherapy in elderly patients with early-stage breast cancer: changes in practice patterns after publication of Cancer and Leukemia Group B 9343. 
  • The use of radiation therapy in localized high-grade soft tissue sarcoma and potential impact on survival. 
  • Thirty years of rectal cancer research: a brief history. 
  • Thoracic radiation therapy added to chemotherapy for small-cell lung cancer: an update of Cancer and Leukemia Group B Study 8083. 
  • Thymoma: benign appearance, malignant potential. 
  • Timing and patterns of recurrences and deaths from prostate cancer following adjuvant pelvic radiotherapy for pathologic stage T3/4 adenocarcinoma of the prostate. 
  • Timing of local and distant failure in resected lung cancer: implications for reported rates of local failure. 
  • Timing of surgery and radiotherapy in the management of metastatic spine disease: a systematic review. 
  • Toxicity of definitive and post-operative radiation following ipilimumab in non-small cell lung cancer. 
  • Treatment of newly diagnosed glioblastoma multiforme. 
  • Treatment of patients with pineoblastoma with high dose cyclophosphamide. 
  • Treatment systems guidelines for primary rectal cancer from the 1996 Patterns of Care Study. 
  • Treatment trends and predictors of adjuvant and neoadjuvant therapy for gastric adenocarcinoma in the United States. 
  • Treatment-induced changes in vocal cord mobility and subsequent local recurrence after organ preservation therapy for laryngeal carcinoma. 
  • Trends and outcomes in the use of surgery and radiation for the treatment of locally advanced esophageal cancer: a propensity score adjusted analysis of the surveillance, epidemiology, and end results registry from 1998 to 2008. 
  • Trends in Treatment Patterns and Outcomes for Ductal Carcinoma In Situ. 
  • Uncorrectable ptosis: primary cutaneous signet-ring cell carcinoma. 
  • Update on combined-modality treatment options for pancreatic cancer. 
  • VATS versus open surgery for lung cancer resection: moving toward a minimally invasive approach. 
  • Validation of a genomic classifier for prediction of metastasis and prostate cancer-specific mortality in African-American men following radical prostatectomy in an equal access healthcare setting. 
  • Value of surgical resection in children with high-risk neuroblastoma. 
  • Video-assisted wedge resection and local radiotherapy for peripheral lung cancer in high-risk patients: the Cancer and Leukemia Group B (CALGB) 9335, a phase II, multi-institutional cooperative group study. 
  • Volume of resection in patients treated with breast conservation for ductal carcinoma in situ. 
  • Well differentiated astrocytoma occurring nine years after radiation therapy for medulloblastoma. 
  • What's new in neoadjuvant therapy for breast cancer? 
  • Who merits a neck dissection after definitive chemoradiotherapy for N2-N3 squamous cell head and neck cancer? 
  • Yes or no to local therapy for oligometastatic prostate cancer? 
  • [Adjuvant therapy of surgically removed stage I melanoma]. 
• 

  Keywords of People

  • Abbruzzese, James, D. C. I. Distinguished Professor of Medical Oncology, Medicine, Medical Oncology
  • Berchuck, Andrew, James M. Ingram Distinguished Professor of Gynecologic Oncology, Obstetrics and Gynecology, Gynecologic Oncology
  • Cohen, Seth Morris, Professor of Head and Neck Surgery & Communication Sciences, Head and Neck Surgery & Communication Sciences
  • Craciunescu, Oana, Professor of Radiation Oncology, Radiation Oncology
  • Jowell, Paul Simon, Professor of Medicine, Medicine, Gastroenterology
  • Lee, Walter T, Professor of Head and Neck Surgery & Communication Sciences, Radiation Oncology
  • McLendon, Roger Edwin, Professor of Pathology, Pathology
  • Reed, Shelby Derene, Professor in Population Health Sciences, Duke Science & Society
  • Sampson, John Howard, Robert H., M.D. and Gloria Wilkins Professor of Neurosurgery, in the School of Medicine, Biomedical Engineering
  • Stinnett, Sandra Sue, Associate Professor of Biostatistics & Bioinformatics, Biostatistics & Bioinformatics
  • Woodward, Julie Ann, Professor of Ophthalmology, Dermatology